FGFR2 and intrahepatic cholangiocarcinoma: Similarly, genetic ablation of Fgfr isoforms in MEFs and human prostate cancer cells (Liu et al., 2018), as well as FGFR inhibition in FGFR2-mutant ICC cells (Zhen et al., 2024), results in suppressed lactate production.